Cocoa Flavanols and Brain Perfusion
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Foods and beverages rich in flavonoids are being heralded as potential preventive agents for a range of pathologic conditions, ranging from hypertension to coronary heart disease to stroke and dementia. We and others have demonstrated that short-term ingestion of cocoa, particularly rich in the subclass of flavonoids known as flavanols, induced a consistent and striking peripheral vasodilation in healthy people, improving endothelial function in a nitric oxide-dependent manner. The vasodilator response was reversed by N-nitro-L-arginine methyl ester, an arginine analog that blocks nitric oxide synthesis. Flavanol-poor cocoa induced much smaller responses. Because impairment of endothelial function is a nearly universal accompaniment of the aging process, we examined the peripheral vasodilator response to flavanol-rich cocoa in healthy older subjects. Observations point to a favorable response among the older. Together with peripheral vascular disease, cerebrovascular disease is responsible for significant mortality with advancing age. An association of decreased cerebral perfusion with dementia has been recently highlighted. The prospect of increasing cerebral perfusion with cocoa flavanols is extremely promising. Our still preliminary data hold out the promise that the cerebral blood supply in the elderly participates in the vasodilator response. With the modalities of transcranial Doppler and MRI, we have the capabilities of analyzing the potential benefits of flavanols on brain perfusion and, subsequently, on cognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dietary Intake of Antioxidants and Risk of Alzheimer Disease
Engelhart, M. J. (2002) · JAMA · doi:10.1001/jama.287.24.3223 · Cited by 1,080
Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study
Ruitenberg, A., den Heijer, T., Bakker, S. L. M., van Swieten, J. C., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20493 · Cited by 733
Vascular risk factors for Alzheimer’s disease:
Breteler, M. M. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00110-4 · Cited by 664 · cited 3×
“First, on the basis of epidemiologic studies, a remarkable number of risk factors are apparently shared between AD and VD.22,23 These risk factors include increasing age, ApoE4 genotype, hypertension, arteriosclerosis, diabetes mellitus, smoking, and atrial fibrillation.22 Second, clinical manifestations of pathologic…”
BackgroundGrassi, D., Necozione, S., Lippi, C., Croce, G., Valeri, L., Pasqualetti, P., Desideri, G., Blumberg, J. B., & Ferri, C. (2005) · Hypertension · doi:10.1161/01.hyp.0000174990.46027.70 · Cited by 546 · cited 1×
“The response has also been demonstrated in patients with increased cardiovascular risk.(15,16) FIGURE 1.”
BackgroundPreclinical prediction of Alzheimer's disease using SPECT
Johnson, K. A., Jones, K., Holman, B. L., Becker, J. A., Spiers, P. A., Satlin, A., & Albert, M. S. (1998) · Neurology · doi:10.1212/wnl.50.6.1563 · Cited by 471 · cited 4×
“Their data suggest that cerebral hypoperfusion precedes and possibly contributes to the onset of clinical dementia.30 Using single-photon emission computed tomography, other groups have also found that that CBF in certain brain regions, including prefrontal and inferior parietal cortices, was significantly lower in th…”
BackgroundInfluentialDementia after ischemic stroke: A population-based study in Rochester, Minnesota (1960-1984)
Kokmen, E., Whisnant, J. P., O'Fallon, W. M., Chu, C.-P., & Beard, C. M. (1996) · Neurology · doi:10.1212/wnl.46.1.154 · Cited by 434
Vascular effects of cocoa rich in flavan-3-ols
Heiss, C. (2003) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.290.8.1030 · Cited by 425 · cited 1×
“The response has also been demonstrated in patients with increased cardiovascular risk.(15,16) FIGURE 1.”
Background
Cited by
Del Rio, D., Rodriguez-Mateos, A., Spencer, J. P. E., Tognolini, M., Borges, G., & Crozier, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4581 · Cited by 2,601
“In support of these findings, arterial spin-labeling sequence magnetic resonance imaging also indicates that flavan-3-ols increase CBF up to a maximum of 2 h after ingestion (142).”
The neuroprotective potential of flavonoids: a multiplicity of effects
Vauzour, D., Vafeiadou, K., Rodriguez-Mateos, A., Rendeiro, C., & Spencer, J. P. E. (2008) · Genes & Nutrition · doi:10.1007/s12263-008-0091-4 · Cited by 559
Williams, R. J., & Spencer, J. P. E. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.010 · Cited by 448
Cocoa and Chocolate in Human Health and Disease
Katz, D. L., Doughty, K., & Ali, A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3697 · Cited by 441
Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances
Toda, N., Ayajiki, K., & Okamura, T. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000547 · Cited by 386
Metadata
- Authors
- Fisher, N. D. L., Sorond, F. A., & Hollenberg, N. K.
- Venue
- Journal of Cardiovascular Pharmacology
- Published
- 2006-06
- Volume
- 47
- Issue
- Supplement 2
- Pages
- S210-S214
- ISSN
- 0160-2446 (ISSN-L)
- OpenAlex
- W2094807620
- Cited by
- 119
- References
- 7
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cocoa Flavanols and Brain Perfusion. https://app.cochat.ai/papers/10.1097/00005344-200606001-00017
- The paper
- Fisher, N. D. L., Sorond, F. A., & Hollenberg, N. K. (2006). Cocoa Flavanols and Brain Perfusion. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/00005344-200606001-00017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.